iifl-logo

Vijaya Diagnostic Centre Ltd Board Meeting

961.95
(-1.17%)
Apr 2, 2025|12:24:57 PM

Vijaya Diagnost. CORPORATE ACTIONS

02/04/2024calendar-icon
02/04/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting12 Feb 20256 Feb 2025
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the Unaudited (Standalone And Consolidated) Financial Results of the Company for the Quarter And Nine Months Ended December 31 2024. Unaudited Financial Results for the third quarter and nine months ended 31 December 2024 (As Per BSE Announcement Dated on: 12/02/2025)
Board Meeting7 Nov 202429 Oct 2024
Quarterly Results As per attachment (As Per BSE Announcement Dated on: 07/11/2024)
Board Meeting5 Aug 202427 Jul 2024
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the first quarter ended June 30 2024; and Other corporate matters. Please find enclosed herewith the Outcome of Board meeting held on Aug 05, 2024 (As per BSE Announcement Dated on 05/08/2024)
Board Meeting8 May 202429 Apr 2024
Final Dividend & Audited Results Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve 1. The standalone and consolidated audited financial results of the Company for the quarter and year ended March 31, 2024; 2. Recommend the dividend, if any, for the financial year ended March 31, 2024; and 3. Other corporate matters Outcome of Board meeting held on May 08, 2024. as per attachment Recommendation of Final Dividend of ?1/- per equity share i.e., 100% of the face value, for the financial year ended March 31, 2024 Re-appointment of Whole-time Directors. Re-appointment of Cost Auditor for FY2024-25 Grant of 2,41,470 ESOPs under the Employee Stock Option Plan 2018 (As Per BSE Announcement Dated on 08/05/2024)

Vijaya Diagnost.: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.